- Plus Therapeutics. (NASDAQ:PSTV) +63% in-licenses novel oncology candidates.
- More news on: Plus Therapeutics, Inc., Bellerophon Therapeutics, Inc., Owens & Minor, Inc., Stocks on the move, , Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
TRxADE (NASDAQ: MEDS) today announced that its board of directors has declared a special cash dividend of $1.50 per share of common stock. According to the announcement, the special dividend is being paid using a portion of the proceeds received in May 2024 in connection with the prior sale of t...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 20.9% to $0.5541 on volume of 173,316,620 shares Assure Holdings Corp. (IONM) rose 114.1% to $0.496799 on volume of 118,668,589 shares NLS Pharmaceutics Ltd. (NLSP) rose 67.6% to $0...
TAMPA, FL, June 27, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. ( Nasdaq: MEDS ) (the “ Company ”), announced today that with the filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Form 10-Q”), the Company regained complianc...